Association of Dipeptidyl Peptidase-4 Inhibitors with Glaucoma Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Chien‐Hsiang Weng (ORCID: https://orcid.org/0000-0002-0794-1263)
- Der‐Yang Cho (ORCID: https://orcid.org/0000-0002-6429-3565)
- I‐Jong Wang (ORCID: https://orcid.org/0000-0002-3045-0614)
- Peng‐Tai Tien (ORCID: https://orcid.org/0000-0002-9099-3151)
- Shang‐Feng Tsai (ORCID: https://orcid.org/0000-0002-6119-0587)
- Yi‐An Lu (ORCID: https://orcid.org/0000-0003-3532-7399)
- Yih‐Dih Cheng (ORCID: https://orcid.org/0000-0003-1542-6760)
- Chien‐Chih Chou (ORCID: https://orcid.org/0000-0003-3332-0900)
- Heng-Jun Lin (ORCID: https://orcid.org/0009-0003-1187-5494)
- Hui‐Ju Lin (ORCID: https://orcid.org/0000-0003-2606-8540)
- Yow‐Wen Hsieh (ORCID: https://orcid.org/0000-0002-0523-3482)
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Tunghai University (TW)
- China Medical University (TW)
- Brown University (US)
- Taichung Veterans General Hospital (TW)
- China Medical University Hospital (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.xops.2025.100827
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health and Welfare
- China Medical University Hospital
- Taichung Veterans General Hospital